SCHEMBL3051802

SCHEMBL3051802

CS(=O)(=O)c1c[c]cc(S(C)(=O)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.39
G6PD P11413 1/20 0.34
IDE P14735 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PTGS2 P35354 5/20 0.32
LMNA P02545 1/20 0.32
TGM2 P21980 1/20 0.31
PNMT P11086 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27530286 0.85 PTGS2 (0.35) ENPP2G6PDIDESMN1; SMN2PTGS2
SCHEMBL15094420 0.85 PTGS2 (0.37) ENPP2PTGS2LMNA
SCHEMBL27224554 0.84 ENPP2 (0.32) ENPP2PTGS2
SCHEMBL1528953 0.84 PTGS2 (0.39) PTGS2
SCHEMBL28987499 0.83 ALDH1A1 (0.39) SMN1; SMN2PTGS2LMNA
SCHEMBL1334156 0.78 ENPP2 (0.48) ENPP2G6PDIDESMN1; SMN2PTGS2
SCHEMBL3193914 0.78 ENPP2 (0.39) ENPP2G6PDIDESMN1; SMN2PTGS2
SCHEMBL27224546 0.74 NR1H2 (0.34)
SCHEMBL27224556 0.74 PTGS2 (0.40) SMN1; SMN2PTGS2LMNA
SCHEMBL17290775 0.74 PSIP1 (0.46) SMN1; SMN2PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3904350-B1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES BAYER AG (DE) 2023-08-23 EP claimed
EP-3904350-A1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES Bayer Aktiengesellschaft (DE) 2021-11-03 EP claimed
US-20210147387-A1 NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 US claimed
EP-3774778-A1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES Bayer Aktiengesellschaft (DE) 2021-02-17 EP claimed
WO-2019197468-A1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2019-10-17 WO claimed
US-10314831-B2 RAC1 inhibitors of neurofibroma formation INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2019-06-11 US claimed
US-20160317516-A1 RAC1 INHIBITORS OF NEUROFIBROMA FORMATION INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION 2016-11-03 US claimed
WO-2015108966-A2 RAC1 INHIBITORS OF NEUROFIBROMA FORMATION INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-07-23 WO claimed
US-4073783-A PENICILLINS PFIZER INC. (US) 1978-02-14 US claimed
EP-3904350-B1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES BAYER AG (DE) 2023-08-23 EP disclosed
EP-3904349-A2 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}HETEROCYCLYL AMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES Bayer Aktiengesellschaft (DE) 2021-11-03 EP disclosed
EP-3904350-A1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES Bayer Aktiengesellschaft (DE) 2021-11-03 EP disclosed
US-20210147387-A1 NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 2021-05-20 US disclosed
EP-3774778-A1 N-(CYCLOPROPYLMETHYL)-5-(METHYLSULFONYL)-N-{1-[1-(PYRIMIDIN-2-YL)-1H-1,2,4-TRIAZOL-5-YL]ETHYL}BENZAMIDE DERIVATIVES AND THE CORRESPONDING PYRIDINE-CARBOXAMIDE DERIVATIVES AS PESTICIDES Bayer Aktiengesellschaft (DE) 2021-02-17 EP disclosed
US-8232420-B2 Asymmetric catalyst and process for preparing optically active alcohols using the same KANTO KAGAKU KABUSHIKI KAISHA (JP) 2012-07-31 US disclosed
US-20100261924-A1 ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME KANTO KAGAKU KABUSHIKI KAISHA (JP) 2010-10-14 US disclosed
EP-2239057-A1 Asymmetric catalyst and process for preparing optically active alcohols using the same Kanto Kagaku Kabushiki Kaisha (JP) 2010-10-13 EP disclosed
EP-0866367-A2 Radiation sensitive composition JSR Corporation (JP) 1998-09-23 EP disclosed
US-4920029-A INCORPORATING A NONDIFFUSING HYDRAZINE DERIVATIVE AND LIGHT-INSENSITIVE HYDROPHILIC COLLOID; ANTISOILANTS; ELIMINATION OF BLACK SPOTS FUJI PHOTO FILM CO., LTD. (JP) 1990-04-24 US disclosed
US-4824764-A HIGH CONTRAST IMAGES FUJI PHOTO FILM CO., LTD. (JP) 1989-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261924-A1 ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME ADH1A, ADH1C, ADH5 ENPP2 3728/4885G6PD 2976/4885IDE 1700/4885
US-20210147387-A1 NOVEL HETEROARYL-TRIAZOLE AND HETEROARYL-TETRAZOLE COMPOUNDS AS PESTICIDES CYP4F3, TARS2, H1-3 ENPP2 1796/4885G6PD 4014/4885IDE 2641/4885
US-10314831-B2 RAC1 inhibitors of neurofibroma formation RAC1, HRAS, KRAS ENPP2 1675/4885G6PD 3000/4885IDE 4427/4885
US-20160317516-A1 RAC1 INHIBITORS OF NEUROFIBROMA FORMATION RAC1, HRAS, KRAS ENPP2 1675/4885G6PD 3000/4885IDE 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.